Scholars Central

Research articlePublished 3 May 2019

Design, synthesis and biological activity of novel substituted 2-Aryl sulfonyl methyl tryptamines as potential 5-HT6 Receptor ligands

Authors: Ramakrishna V. S. Nirogi, Thrinath Reddy Bandyala, Jagadishu Babu Konda, Veena Reballi, Parandhama Gudla, Ramasastri Kambhampati, Mukkanti Khagga

Der Pharma Chemica

Volume 4 · Issue 4 · Pages 1567–1576

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The future of 5-HT6R ligands as potential therapeutic drugs seems quite exciting. There is an increasing research interest in the role of 5-HT6 receptors in higher cognitive processes such as memory, obesity and eating disorder. Selective agents are required for the proposed therapeutic application. A series of novel compounds 6a-t based on substituted 2-Arylsulfonylmethyl tryptamines as potential 5-HT6 receptor ligands is reported. Design, Synthesis, invitro binding data and structure-activity relationship have been discussed. Compound 6i was found to be the most potent, which can be further optimized to get the potential 5-HT6 receptor ligands.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDer Pharma Chemica
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ramakrishna V. S. Nirogi”
  • BylineArticles whose byline prints “Thrinath Reddy Bandyala”
  • BylineArticles whose byline prints “Jagadishu Babu Konda”
  • BylineArticles whose byline prints “Veena Reballi”
  • BylineArticles whose byline prints “Parandhama Gudla”
  • BylineArticles whose byline prints “Ramasastri Kambhampati”
  • BylineArticles whose byline prints “Mukkanti Khagga”